WASHINGTON — For advocates of the National Institutes of Health, this is their worst fear: Come April, when Congress needs to fund the federal government again, they’ll be so busy with other issues that they’ll simply pass a stopgap spending bill that lasts until October.
And that would likely mean another year of flat funding for the NIH. For the scientists and companies invested in medical research, nothing could be worse.
